Uromesan

Uromesan

mesna

Manufacturer:

Sanbe
Concise Prescribing Info
Contents
Mesna
Indications/Uses
Prevention of urothelial toxicity due to oxazaphosphorines.
Dosage/Direction for Use
IV Adult Administer at time 0 (time of oxazaphosphorine administration), after 4 hr & after 8 hr, w/ each dose being 20% of the oxazaphosphorine dose. W/ very high-dose oxazaphosphorine cytostatic therapy (eg, before bone marrow transplantation) Total dose can be increased to between 120% & 160% of the oxazaphosphorine dose. After administration of 20% Uromesan (related to the total dose of oxazaphosphorine) at time 0, the remaining calculated dose should be given continuously IV over a period of 24 hr w/ a perfusor. Intermittent bolus inj Adult 3 x 40% (at times 0, 4, 8 hr) or 4 x 40% (at times 0, 3, 6, 9 hr) respectively. Childn Given in 3-hr intervals (eg, 20% at time 0, 1, 3, 6, 9, 12 hr). Short 15-min infusion are possible. Continuous infusions of ifosfamide Administer at time 0 following the initial 20% bolus inj (start of infusion at time 0), followed by infusion to up to 100% of the ifosfamide dose & continue uroprotection for further 6-12 hr after ifosfamide infusion termination.
Contraindications
Known hypersensitivity to mesna & other thiol-containing compd.
Special Precautions
Hypersensitivity reactions in patients w/ autoimmune disorders. Isolated circulatory reactions w/ hypotension & tachycardia. Protective action applies only to the urinary tract.
Adverse Reactions
Anaphylactoid & other hyperergic reactions; nausea, vomiting, diarrhea, headache, joint pain, drop in BP, tachycardia, skin reactions, exhaustion & weakness.
Drug Interactions
Incompatible in vitro w/ cisplatin, carboplatin & nitrogen mustard.
MIMS Class
Antidotes & Detoxifying Agents / Supportive Care Therapy
ATC Classification
V03AF01 - mesna ; Belongs to the class of detoxifying agents used in antineoplastic treatment.
Presentation/Packing
Form
Uromesan inj 100 mg/mL
Packing/Price
4 mL x 15 × 1's (Rp1,725,000/boks)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in